Prospective and challenges of live bacterial therapeutics from a superhero Escherichia coli Nissle 1917.
Sign Up to like & getrecommendations! Published in 2022 at "Critical reviews in microbiology"
DOI: 10.1080/1040841x.2022.2109405
Abstract: Escherichia coli Nissle 1917 (EcN), the active component of Mutaflor(R), is a notable probiotic from Gram-negative to treat Crohn's disease and irritable bowel syndrome. Therefore, a comprehensive genomic database maximizes the systemic probiotic assessment to… read more here.
Keywords: engineered ecn; nissle 1917; coli nissle; escherichia coli ... See more keywords